Impact of obesity on the evolution of outcomes in peritoneal dialysis patients.
epidemiology
obesity
peritoneal dialysis
Journal
Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
11
01
2020
accepted:
18
03
2020
entrez:
29
3
2021
pubmed:
30
3
2021
medline:
30
3
2021
Statut:
epublish
Résumé
Some studies reveal that obesity is associated with a decrease in mortality in haemodialysis (HD) patients. However, few studies have addressed the association between body mass index (BMI) and peritoneal dialysis (PD) patients. We performed this longitudinal, retrospective study to evaluate the impact of obesity on PD patients, using data from the Catalan Registry of Renal Patients from 2002 to 2015 ( Obesity was observed in 20% of patients starting PD. We did not find differences in sex or PD modality, with the obesity group being older (65.9% are ≥55 years versus 59% non-obese, P = 0.003) and presenting more diabetes mellitus and cardiovascular disease (CVD) (47.9% obese versus 25.1% non-obese and 41.7% versus 31.5%, respectively). We did not observe differences in haemoglobin, albumin and Obese and non-obese patients starting on PD had similar outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Some studies reveal that obesity is associated with a decrease in mortality in haemodialysis (HD) patients. However, few studies have addressed the association between body mass index (BMI) and peritoneal dialysis (PD) patients.
METHODS
METHODS
We performed this longitudinal, retrospective study to evaluate the impact of obesity on PD patients, using data from the Catalan Registry of Renal Patients from 2002 to 2015 (
RESULTS
RESULTS
Obesity was observed in 20% of patients starting PD. We did not find differences in sex or PD modality, with the obesity group being older (65.9% are ≥55 years versus 59% non-obese, P = 0.003) and presenting more diabetes mellitus and cardiovascular disease (CVD) (47.9% obese versus 25.1% non-obese and 41.7% versus 31.5%, respectively). We did not observe differences in haemoglobin, albumin and
CONCLUSIONS
CONCLUSIONS
Obese and non-obese patients starting on PD had similar outcomes.
Identifiants
pubmed: 33777380
doi: 10.1093/ckj/sfaa055
pii: sfaa055
pmc: PMC7986361
doi:
Types de publication
Journal Article
Langues
eng
Pagination
969-982Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA.
Références
Perit Dial Int. 2002 Mar-Apr;22(2):191-6
pubmed: 11990403
Perit Dial Int. 2016 May-Jun;36(3):315-25
pubmed: 26475847
Adv Chronic Kidney Dis. 2013 Mar;20(2):128-34
pubmed: 23439371
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
J Am Soc Nephrol. 2003 Nov;14(11):2894-901
pubmed: 14569099
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
PLoS One. 2013 Jul 30;8(7):e65174
pubmed: 23935815
Am J Kidney Dis. 2000 Jan;35(1):80-8
pubmed: 10620548
Perit Dial Int. 2003 May-Jun;23(3):249-54
pubmed: 12938825
Mayo Clin Proc. 2013 May;88(5):479-86
pubmed: 23562348
Kidney Int. 2008 Feb;73(4):480-8
pubmed: 18046315
Nephrol Dial Transplant. 2012 Sep;27(9):3631-8
pubmed: 22553372
Clinics (Sao Paulo). 2013 Jan;68(1):51-8
pubmed: 23420157
Kidney Int. 2003 Nov;64(5):1838-44
pubmed: 14531819
Perit Dial Int. 2014 Jun;34(4):399-408
pubmed: 24584600
Am J Med Sci. 2017 Jan;353(1):70-75
pubmed: 28104106
Int Urol Nephrol. 2007;39(1):281-8
pubmed: 17171411
Am J Kidney Dis. 2011 Oct;58(4):574-82
pubmed: 21658829
Perit Dial Int. 2003 May-Jun;23(3):276-83
pubmed: 12938830
Perit Dial Int. 2004 Jul-Aug;24(4):340-6
pubmed: 15335147
Perit Dial Int. 2017 1-2;37(1):35-43
pubmed: 27147287
Blood Purif. 2005;23(1):57-63
pubmed: 15627738
Am J Kidney Dis. 2018 Jun;71(6):802-813
pubmed: 29223620
Am J Kidney Dis. 2005 Sep;46(3):489-500
pubmed: 16129211
Kidney Int. 2003 Mar;63(3):793-808
pubmed: 12631061